Brief: Corline Biomedical Enters Licence And Delivery Deal
Sept 7 (Reuters) - Corline Biomedical AB CLBIO.ST :
* ENTERS LICENCE AND DELIVERY DEAL
* FULLY LAUNCHED PRODUCT IS ESTIMATED TO GENERATE YEARLY
REVENUE
FOR CO OF SEK 50 MILLION
* DEAL WITH CANADIAN COMPANY KARDIUM
Source text for Eikon: ID:nGNE9NYZZC
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln